← All companies
Sarepta Therapeutics, Inc.
SRPT - CIK 0000873303
Market cap$1.88 B
Rank#2138
SEC filings1,504
The table below shows Sarepta Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $801.28M | $1.10B | $428.43M | $966.78M | $2.12B | $1.50B |
| Short-term investments | $138.37M | $251.78M | $1.25B | $1.02B | $435.92M | $435.92M |
| Receivables | $398.23M | $601.99M | $400.33M | $214.63M | $152.99M | $101.34M |
| Inventory | $914.74M | $749.96M | $322.86M | $203.97M | $186.21M | $231.96M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.